Newsroom

Novartis is working to tackle the problem of counterfeit drugs, which are a threat to patient health.

Patients with glaucoma, which affects 60 million people worldwide, can lose up to 40 percent of their sight before they begin to notice any change in vision.

Raising a child with a rare disease can feel overwhelming and isolating, but many parents end up being extremely proud of their children’s achievements.

Parents and doctors can help children understand rare diseases like TSC and SJIA with the help of cartoon dogs and comic book superheroes.

After 40 years of working in information technology, Jim Barrington took a partial retirement from his job as Novartis’ chief information officer and started looking for new ways to apply his skills.

With extensive experience in public health management, having worked for the International Red Cross, among others, and as a doctor in emergency situations on the ground in Africa and Asia— Ann Aerts discusses the Novartis Foundation's new leprosy strategy.

An antibody that boosts muscle mass could mean independence for the frail and elderly. Learn how Novartis research aims to improve healthy aging.

University students majoring in the life sciences or business often have trouble imagining the direction of their careers.

To raise awareness of the sudden and profound impact of meningococcal disease on families across the globe, world-renowned photographer Anne Geddes has joined forces with the Confederation of Meningitis Organizations (CoMO) and Novartis Vaccines and Diagnostics for the Protecting Our Tomorrows: Portraits of Meningococcal Disease project.

Using new technologies, researchers have developed a deeper understanding of how cells function, changing conceptions of disease.